Circle Square Digital Health Trends – June 2022

Published: July 6, 2022

6th July 2022 – Contribution by Alex Green – Featured in Circle Square Digital Health Trends June Newsletter.

Can Oracle Cerner dramatically impact the healthcare landscape?

Oracle announced plans for a national patient database among other ideas

Why now?

What has changed to make a national EHR overlay viable?

The Affordable Care Act (ACA) has changed healthcare structures and the technology deployed significantly. Some barriers have come down with HIE, PHM and data integration tools from Health Catalyst, Innovaccer, InterSystems, Lyniate, AWS, Google, Redox, Epic and Oracle Cerner itself. These offer a starting blueprint. Internationally there are pockets of success in terms of countries adopting a national EHR database while still using local instances of an EHR for
provider operational use.

Why Oracle Cerner?

Who else could do it and what is the strength of Oracle

InterSystems already has some experience at a national level in the US in providing technology  for a network of regional/state HIEs (HealthShare). Oracle Cerner has credentials given its large installed base of US hospital and physician practice customers (although Epic has about a third of the market). HealtheIntent, its summary care record supports 200 US customers and 25% in
the UK. Scaling it would take work. Oracle has not announced this as its foundation for its national EHR but could be a candidate.

What’s the real idea?

Maybe it is focused on Cerner data and life sciences research.

The EHR database was one of several elements of the Oracle Cerner vision. These included new products in and out of healthcare that included voice navigation, virtual visits, remote
monitoring, and others. It also included leveraging a subset of real-world data for life sciences,
pharma and others with a rich environment for research, clinical trials, and drug development.
This is a more near term and achievable element of its vision and a compelling value proposition.

Editorial: There has been a lot of recent press about the $28 billion acquisition of Cerner by Oracle. Most recently, Oracle announced plans for a US national patient database that would
maintain both de-identified patient data, as well as, with patient consent, patient health records to be used in care delivery. Alex Green, a partner and analyst at the UK-based Signify
Research, and an expert in global EHR adoption and use, sees the possibilities in the Oracle Cerner vision, and in some very real, near-term opportunities in real-world data and pharma.

Visit for more information on their monthly newsletter…